跳转至内容
Merck

GERPN3243

ECL Start Western Blotting Detection Reagent

Cytiva RPN3243, pkg of 200 mL

登录查看公司和协议定价


About This Item

分類程式碼代碼:
41105332
NACRES:
NA.32

包裝

pkg of 200 mL

製造商/商標名

Cytiva RPN3243

儲存溫度

room temp

正在寻找类似产品? 访问 产品对比指南

一般說明

Amersham ECL start is a chemiluminescent detection reagent in the Amersham ECL product family that is recommended for confirmatory analysis and detection of high to medium levels of endogenous proteins. Amersham ECL start has a long signal duration, which enables multiple exposures of the membrane, plus a convenient time window between experiment and analysis.

應用

ECL Start western blotting detection reagent has been used in western blotting.

特點和優勢

  • Flexibility: Long signal duration provides assay design flexibility and robust detection of large experimental sets.
  • Low background: Produces low background, regardless of the method of detection.
  • Stability of the working solution: The working solution is stable for 5 days.
  • Long shelf life: A long shelf life of 18 months is convenient for those who run Western blots infrequently.

儲存和穩定性

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

分析報告

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

法律資訊

ECL is a trademark of Cytiva

儲存類別代碼

12 - Non Combustible Liquids

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Starlee Lively et al.
Frontiers in cellular neuroscience, 12, 433-433 (2018-12-14)
Addressing potential sex differences in pre-clinical studies is crucial for developing therapeutic interventions. Although sex differences have been reported in epidemiological studies and from clinical experience, most pre-clinical studies of neuroinflammation use male rodents; however, sexual dimorphisms in microglia might
Starlee Lively et al.
Frontiers in cellular neuroscience, 12, 115-115 (2018-05-22)
The cytokine, transforming growth factor β1 (TGFβ1), is up-regulated after central nervous system (CNS) injuries or diseases involving microglial activation, and it has been proposed as a therapeutic agent for treating neuroinflammation. Microglia can produce and respond to TGFβ1. While
Grégoire Stik et al.
Nature genetics, 52(7), 655-661 (2020-06-10)
Three-dimensional organization of the genome is important for transcriptional regulation1-7. In mammals, CTCF and the cohesin complex create submegabase structures with elevated internal chromatin contact frequencies, called topologically associating domains (TADs)8-12. Although TADs can contribute to transcriptional regulation, ablation of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门